210 related articles for article (PubMed ID: 37047148)
21. A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood-Brain Barrier Endothelial Cell Line hCMEC/D3.
Higuchi K; Sivaprakasam S; Sennoune SR; Ogura J; Bhutia YD; Rueda R; Pereira SL; Ganapathy V
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579098
[TBL] [Abstract][Full Text] [Related]
22. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).
Kongpracha P; Nagamori S; Wiriyasermkul P; Tanaka Y; Kaneda K; Okuda S; Ohgaki R; Kanai Y
J Pharmacol Sci; 2017 Feb; 133(2):96-102. PubMed ID: 28242177
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
[TBL] [Abstract][Full Text] [Related]
25. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
26. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
[TBL] [Abstract][Full Text] [Related]
27. The Regulatory Role of MeAIB in Protein Metabolism and the mTOR Signaling Pathway in Porcine Enterocytes.
Tang Y; Tan B; Li G; Li J; Ji P; Yin Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498661
[TBL] [Abstract][Full Text] [Related]
28. Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.
Hayashi K; Anzai N
World J Gastrointest Oncol; 2017 Jan; 9(1):21-29. PubMed ID: 28144396
[TBL] [Abstract][Full Text] [Related]
29. EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer.
Zhang BK; Moran AM; Bailey CG; Rasko JEJ; Holst J; Wang Q
Cell Commun Signal; 2019 Jul; 17(1):83. PubMed ID: 31345230
[TBL] [Abstract][Full Text] [Related]
30. Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis.
Markowicz-Piasecka M; Huttunen J; Montaser A; Huttunen KM
Apoptosis; 2020 Jun; 25(5-6):426-440. PubMed ID: 32405891
[TBL] [Abstract][Full Text] [Related]
31. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.
Wang Q; Holst J
Am J Cancer Res; 2015; 5(4):1281-94. PubMed ID: 26101697
[TBL] [Abstract][Full Text] [Related]
32. The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.
Salisbury TB; Arthur S
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103560
[TBL] [Abstract][Full Text] [Related]
33. Abundance of amino acid transporters involved in mTORC1 activation in skeletal muscle of neonatal pigs is developmentally regulated.
Suryawan A; Nguyen HV; Almonaci RD; Davis TA
Amino Acids; 2013 Sep; 45(3):523-30. PubMed ID: 22643846
[TBL] [Abstract][Full Text] [Related]
34. Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.
Schcolnik-Cabrera A; Juárez-López D
Cell Oncol (Dordr); 2022 Oct; 45(5):831-859. PubMed ID: 36036882
[TBL] [Abstract][Full Text] [Related]
35. L-Theanine Regulates the Abundance of Amino Acid Transporters in Mice Duodenum and Jejunum via the mTOR Signaling Pathway.
Liu K; Peng Y; Lin L; Gong Z; Xiao W; Li Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615799
[TBL] [Abstract][Full Text] [Related]
36. L-Type Amino Acid Transporter 1 Regulates Cancer Stemness and the Expression of Programmed Cell Death 1 Ligand 1 in Lung Cancer Cells.
Liu YH; Li YL; Shen HT; Chien PJ; Sheu GT; Wang BY; Chang WW
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681614
[TBL] [Abstract][Full Text] [Related]
37. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
38. Amino acid transporters in the regulation of human skeletal muscle protein metabolism.
Dickinson JM; Rasmussen BB
Curr Opin Clin Nutr Metab Care; 2013 Nov; 16(6):638-44. PubMed ID: 24100668
[TBL] [Abstract][Full Text] [Related]
39. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.
Bitting RL; Armstrong AJ
Endocr Relat Cancer; 2013 Jun; 20(3):R83-99. PubMed ID: 23456430
[TBL] [Abstract][Full Text] [Related]
40. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
Kantipudi S; Fotiadis D
Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
